Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses

Journal of Experimental Medicine

Volumn 182, Issue 6, 1995, Pages 1673-1682

  Kusunoki, Takashi ^a   Hailman, Eric ^a   Juan, Todd S C ^b   Lichenstein, Henri S ^b   Wright, Samuel D ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN;

ANTIGEN BINDING; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IMMUNITY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTIGENS, BACTERIAL; ANTIGENS, CD14; CELL ADHESION; HUMAN; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MONOCYTES; NEUTROPHILS; PROTEIN BINDING; RECOMBINANT PROTEINS; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, U.S. GOV'T, P.H.S.; TEICHOIC ACIDS; TUMOR CELLS, CULTURED;

EID: 0028800982     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.6.1673     Document Type: Article

References (49)

1. Natanson, C., R.L. Danner, R.J. Elin, J.M. Hosseini, K.W. Peart, S.M. Banks, T.J. MacVittie, R.I. Walker, andJ.E. Parrillo. 1989. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus, challenges in a canine model, of human septic shock. J. Clin. Invest. 83: 243-251.
2. Wakabayashi, G., J.A. Gelfand, W.K. Jung, R.J. Connolly, J.F. Burke, and C.A. Dinarello. 1991. Staphylococcus epidermidis induces component activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. J. Clin. Invest. 87: 1925-1935.
3. Hinshaw, L.B., T.E. Emerson, F.B. Taylor, A.C.K. Chang, M. Duerr, G.T. Peer, D.J. Fluomoy, G.L. White, S.D. Kosanke, C.K. Murray, et al. 1992. Lethal Staphylococcus aureusinduced shock in primates: prevention of death with antiTNF antibody. J. Trauma. 33: 568-573.
4. Timmerman, C.P., E. Mattsson, L. Martinez-Martinez, L. De Graaf, J.A.G. Van Strijp, H.A. Verbrugh, J. Verhoef, and A. Fleer. 1993. Induction of release of tumor necrosis factor from human monocytes by Staphylococci and stapholococcal peptidoglycans. Infect. Immun. 61: 4167-4172.
5. Freudenberg, M.A., and C. Galanos. 1991. Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect. Immun. 59: 2110-2115.
6. Wright, S.D. 1995. CD14 and innate recognition of bacteria. J. Immunol. 155: 6-8.
7. Schumann, R.R., S.R. Leong, G.W. Flaggs, P.W. Gray, S.D. Wright, J.C. Mathison, P.S. Tobias, and R.J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science (Wash. DC). 249: 1429-1431.
8. Hailman, E., H.S. Lichenstein, M.M. Wurfel, D.S. Miller, D.A. Johnson, M. Kelley, L.A. Busse, M.M. Zukowski, and S.D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD D.J. Exp. Med. 179: 269-277.
9. Wurfel, M.M., E. Hailman, and S.D. Wright. 1995. Soluble CD 14 acts as a shuttle in the neutralization of lipopolysaccharide by LPS-binding protein and reconstituted high density lipoprotein. J. Exp. Med. 181: 1743-1754.
10. Detmers, P.A., D. Zhou, and D.E. Powell. 1994. Different signalling pathways for CD18-mediated adhesion and Fcmediated phagocytosis: response of neutrophils to LPS.J. Immunol. 153: 2137-2145.
11. Wright, S.D., R.A. Ramos, A. Hermanowski-Vosatka, P. Rockwell, and P.A. Detmers. 1991. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J. Exp. Med. 173: 1281-1286.
12. Frey, E.A., D.S. Miller, T.G. Jahr, A. Sundan, V. Bazil T. Espevik, B.B. Finlay, and S.D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176: 1665-1671.
13. Tomasz, A., and K. Saukkonen. 1989. The nature of cell wall-derived inflammatory components of Pneumococci. Pediatr. Infect. Dis.J. 8: 902-903.
14. Lambert, P.A., I.C. Hancock, andj. Baddiley. 1977. Occurrence and function of membrane teichoic acids. Biochim. Biophys. Acta. 472: 1-12.
15. Fischer, W. 1989. Bacterial phosphoglycolipids and lipoteichoic acids. In Handbook of Lipid Research. D.J. Hannah, editor. Plenum, NY. 123-234.
16. Fischer, W., H.U. Koch, and R. Haas. 1983. Improved preparation of lipoteichoic acids. Eur.J. Biochem. 133: 523-530.
17. Dinarello, C.A., R.J. Elin, L. Chedid, and S.M. Wolff. 1978. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. J. Infect. Dis. 138: 760-767.
18. Mattsson, E., L. Verhage, J. Rollof, A. Fleer, J. Verhoef, and H. van Dijk. 1993. Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-a, interleukin-1 (3 and interleukin-6. FEMS Immunol. Med. Microbiol. 7: 281-288.
19. Riesenfeld-Om, I., S. Wolpe, J.F. Garcia-Bustos, M.K. Hoffmann, and E. Tuomanen. 1989. Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect. Immun. 57: 1890-1893.
20. Heumann, D., C. Barras, A. Severin, M.P. Glauser, and A. Tomasz. 1994. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62: 2715-2721.
21. Bahkdi, S., T. Klonisch, P. Nuber, and W. Fischer. 1991. Stimulation of monokine production by lipoteichoic acids. Infect. Immun. 59: 4614-4620.
22. Standiford, T.J., D.A. Arenberg, J.M. Danforth, S.L. Kunkel, G.M. VanOtteren, and R.M. Strieter. 1994. Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infect. Immun. 62: 119-125.
23. Keller, R., W. Fischer, R. Keist, and S. Bassetti. 1992. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect. Immun. 60: 3664-3672.
24. Juan, T.S., M.J. Kelley, D.A. Johnson, L.A. Busse, E. Hailman, S.D. Wright, and H.S. Lichenstein. 1995. Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS. J. Biol. Chem. 270: 1382-1387.
25. Juan, T.S., E. Hailman, M.J. Kelly, L.A. Busse, E. Davy, C.J. Empig, L.O. Narhi, S.D. Wright, and H.S. Lichenstein. 1995. Identification of a lipopolysaccharide-binding domain in CD14 between amino acids 57 and 64. J. Biol. Chem. 270: 5219-5224.
26. Elsbach, P., andj. Weiss. 1995. Prospects for use of recombinant BPI in the treatment of gram-negative bacterial infections. Infectious Agents & Disease. 4: 102-109.
27. Todd, R.F., III, A. Van Agthoven, S.F. Schlossman, and C. Terhorst. 1982. Structural analysis of differentiation antigens Mol and Mo2 on human monocytes. Hybridoma. 1: 329-337.
28. Wright, S.D., P.E. Rao, W.C. Van Voorhis, L.S. Craigmyle, K. Iida, M.A. Talle, E.F. Westberg, G. Goldstein, and S.C. Silverstein. 1983. Identification of the C3bi receptor on human monocytes and macrophages by using monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 80: 5699-5703.
29. Pawlowski, N.A., G. Kaplan, A.L. Hamill, Z.A. Cohn, and W.A. Scott. 1983. Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures. J. Exp. Med. 158: 393-412.
30. Van Kessel, K.P.M., C.T. Park, and S.D. Wright. 1994. A fluorescence microassay for the quantitation of integrinmediated adhesion of neutrophil. J. Immunol. Methods. 172: 25-31.
31. Broekman, M.J. 1989. Endogenous phosphatidylinositol 4,5bisphosphate, phosphatidylinositol, and phosphatidic acid in stimulated human platelets. Methods Enzymol. 169: 415-430.
32. Harlow, E., and D. Lane. 1988. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 651-652.
33. Wright, S.D., R.A. Ramos, P.S. Tobias, R.J. Ulkevitch, and J.C. Mathison. 1990. CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (Wash. DC). 249: 1431-1433.
34. Wright, S.D., R.A. Ramos, M. Patel, and D.S. Miller. 1992. Septin: a factor in plasma that opsonizes lipopolysaccharidebearing particles for recognition by CD 14 on phagocytes. J. Exp. Med. 176:719-727
35. Mathison, J.C., P.S. Tobias, E. Wolfson, and R.J. Ulevitch. 1992. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS J. Immunol. 149: 200-206.
36. McGinley, M.D., L.O. Narhi, M.J. Kelley, E. Davy, J. Robinson, M.F. Rohde, S.D. Wright, and H.S. Lichenstein. 1995. CD14: physical properties and identification of an exposed site that is protected by lipopolysaccharide. J. Biol. Chem. 270: 5213-5218.
37. Lynn, W.A., and D.T. Golenbock. 1992. Lipopolysaccharide antagonists. Immunol. Today. 13: 271-276.
38. Bone, R.C. 1994. Gram-positive organisms and sepsis. Arch. Intern. Med. 154: 26-34.
39. Zhang, Y., M. Doerfler, T.C. Lee, B. Guillemin, and W.N. Rom. 1993. Mechanisms of stimulation of interleukinIP and tumor necrosis factor-a by Mycobacterium tuberculosis components. J. Clin. Invest. 91: 2076-2083.
40. Espevik, T., M. Otterlei, G. Skjak-Braek, L. Ryan, S.D. Wright, and A. Sundan. 1993. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur.J. Immunol. 23: 255-261.
41. Weidemann, B., H. Brade, E.T. Rietschel, R. Dziarski, V. Bazil, S. Kusumoto, H. Flad, and A.J. Ulmer. 1994. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD 14 monoclonal antibodies and by lipid A partial structures. Infect. Immun. 62: 4709-4715.
42. Soell, M., E. Lett, F. Holveck, M. Scholler, D. Wachsmann, andj. Klein. 1995. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD 14 antigen, and mannan binding protein inhibits TNF-a release. J. Immunol. 154: 851-860.
43. Otterlei, M., K.M. Varum, L. Ryan, and T. Espevik. 1994. Characterization of binding and TNF-a-inducing ability of chitosans on monocytes: the involvement of CD14. Vaccine. 12: 825-832.
44. Pugin, J., A. Heumann, A. Tomasz, V. Kravchenko, Y. Akamatsu, M. Nishijima, P. Gluaser, P.S. Tobias, and R.J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity. 1: 509-516.
45. Tsutsui, O., S. Kokeguchi, T. Matsumura, and K. Kato. 1991. Relationship of the chemical structure and immunobiological activities of lipoteichoic acid from Streptococcus faecalis (Enterococcus hirae) ATCC 9790. FEMS Microbiol. Immunol. 76: 211-218.
46. Kotani, S. 1992. Bacterial cell surface biological response modifiers and their synthetic counterparts. Adv. Exp. Med. Biol. 319: 145-164.
47. Takada, H., Y. Kawabata, R. Arakai, S. Kusumoto, K. Fukase, Y. Suda, T. Yoshimura, S. Kokeguchi, K. Kato, T. Komuro, et al. 1995. Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities. Infect. Immun. 63: 57-65.
48. Kitchens, R.L., R.J. Ulevitch, and R.S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176: 485-494.
49. Delude, R.L., R. Savedra, Jr., H. Zhao, R. Thieringer, S. Yamamoto, M.J. Fenton, and D.T. Golenbock. 1995. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. USA. 92: 9288-9292.